# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA620434 | F | Inhibition of Forskolin-Induced cAMP production in A9 L cells expressing m2 receptors | Mus musculus | 8 | ALA1129993 | cell-based format | Scientific Literature | |
2. | ALA620435 | F | Percent inhibition of Forskolin-Induced cAMP production in A9 L cells expressing m2 receptors | Mus musculus | 8 | ALA1129993 | cell-based format | Scientific Literature | |
3. | ALA619658 | F | The increase in phosphoinositide (PI) metabolism in A9L-m1 cells was measured at 100 uM; - = Not determined | Mus musculus | 3 | ALA1125621 | cell-based format | Scientific Literature | |
4. | ALA619660 | F | Increase in phosphoinositide (PI) metabolism in A9L-cholinergic receptor, muscarinic 3 expressing cells was measured at 100 uMolar | 28 | ALA1125621 | assay format | Scientific Literature | ||
5. | ALA874428 | B | Maximum percent of enhancement of binding. | 31 | ALA1123034 | protein complex format | Scientific Literature | ||
6. | ALA638618 | B | Compounds was evaluate for their ability to enhance (+/-)-[3H]nicotine binding at a dose range 2.5*10e-9-7.5*10e-5 M was reported | 1 | ALA1123034 | protein complex format | Scientific Literature | ||
7. | ALA637745 | B | Compound was evaluated for the binding affinity by displacing [3H]methylscopolamine [3H]NMS from mouse cerebral cortex tissue. | 3 | ALA1125408 | tissue-based format | Scientific Literature | ||
8. | ALA637746 | B | Compound was evaluated for the binding affinity by displacing [3H]oxotremorine from mouse cerebral cortex tissue. | 3 | ALA1125408 | tissue-based format | Scientific Literature | ||
9. | ALA637748 | F | NMS/OXO-M values are calculated from the ratio of the respective apparent Ki values | 3 | ALA1125408 | assay format | Scientific Literature | ||
10. | ALA663185 | F | The percent inhibition of cyclic AMP(cAMP) formation in NG108-15 cells at 100 uM. | Mus musculus | 16 | ALA1125621 | cell-based format | Scientific Literature | |
11. | ALA676595 | F | Agonism of endothelin A receptor was determined as maximal rate of vascular endothelium-dependent relaxation at the concentration of 10E-5 M/L | Oryctolagus cuniculus | 9 | ALA1146775 | assay format | Scientific Literature | |
12. | ALA682819 | F | Agonist efficacy was evaluated as concentration that produces 10-m V depolarization in frog sartorius muscle; 6-10 | frog | 1 | ALA1123150 | tissue-based format | Scientific Literature | |
13. | ALA682997 | F | In vitro nicotinic activity was measured on frog rectus abdominis | frog | 5 | ALA1123945 | tissue-based format | Scientific Literature | |
14. | ALA682999 | F | Nicotinic activity on frog rectus abdominis | frog | 7 | ALA1123629 | tissue-based format | Scientific Literature | |
15. | ALA682859 | F | Potency was evaluated on frog rectus abdominis | frog | 4 | ALA1123362 | tissue-based format | Scientific Literature | |
16. | ALA680346 | F | In vitro muscarinic activity was measured on isolated guinea pig ileum | Cavia porcellus | 1 | ALA1123945 | tissue-based format | Scientific Literature | |
17. | ALA684535 | F | In vitro agonistic activity on isolated guinea pig ileum | Cavia porcellus | 9 | ALA1126289 | organism-based format | Scientific Literature | |
18. | ALA684536 | F | In vitro antagonistic activity on isolated guinea pig urinary bladder | Cavia porcellus | 1 | ALA1126289 | organism-based format | Scientific Literature | |
19. | ALA684547 | F | Concentration that elicits 50% of its own maximum contractile response in guinea pig ileum | Cavia porcellus | 6 | ALA1124068 | organism-based format | Scientific Literature | |
20. | ALA684548 | F | Concentration that elicits 50% of its own maximum contractile response in guinea pig urinary bladder | Cavia porcellus | 4 | ALA1124068 | organism-based format | Scientific Literature |